Financials
- Market Capitalization 208.63 M
- Employee 81
- Founded 1999
- CEO N/A
- Website www.agenusbio.com
- Headquarter Delaware, United States
- FIGI BBG000C8SWQ9
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
1.63
ratio cours/chiffre d'affaires
0.86
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3592 | BCYC Bicycle Therapeutics plc - American Depositary Shares | 4.22 USD | +0.24% | -1.63% | +4.98% | -44.91% | 212.58 M USD | ||
| 3603 | RNA Atrium Therapeutics, Inc. - Common Stock | 12.30 USD | +0.65% | -8.21% | -3.38% | -82.51% | 210.40 M USD | ||
| 3616 | IMUX Immunic, Inc. - Common Stock | 15.10 USD | +2.79% | +1.07% | +10.06% | +1577.78% | 205.69 M USD | ||
| 3625 | CLLS Cellectis S.A. - American Depositary Shares | 2.81 USD | -2.43% | -9.65% | -10.51% | +47.12% | 201.62 M USD |